Masashi Kanai
Impact in
- Molecular Medicine top 0.5%
- Curcumin's Biomedical Applications
- Oncology top 2%
- Pancreatic and Hepatic Oncology Research
- Cytokine Signaling Pathways and Interactions
Papers in
- Co-authors
- Shigemi Matsumoto (57 shared papers)Tsutomu Chiba (19 shared papers)Daoyan Wei (4 shared papers)Keping Xie (4 shared papers)Y Nimura (21 shared papers)Junichi Kamiya (17 shared papers)Suyun Huang (2 shared papers)Atsushi Imaizumi (8 shared papers)
- Journals
- Annals of Oncology (12 papers)Journal of Clinical Oncology (10 papers)Cancer Chemotherapy and Pharmacology (9 papers)International Journal of Clinical Oncology (9 papers)Pancreas (4 papers)
- Partner nations
- JapanUnited StatesChina
In The Last Decade
Masashi Kanai
152 papers receiving 3.9k citations
Peers
Comparison fields: 5 of 113
- Molecular Medicine 582
- Oncology 1.1k
- Hepatology 243
- Cancer Research 373
- Surgery 871
Countries citing papers authored by Masashi Kanai
This map shows the geographic impact of Masashi Kanai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Masashi Kanai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Masashi Kanai more than expected).
Fields of papers citing papers by Masashi Kanai
This network shows the impact of papers produced by Masashi Kanai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Masashi Kanai. The network helps show where Masashi Kanai may publish in the future.
Co-authors
The 25 scholars most cited alongside Masashi Kanai, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 163 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2010 | 316 | |
| 2 | 2004 | 268 | |
| 3 | 2005 | 256 | |
| 4 | 2011 | 214 | |
| 5 | 2005 | 183 | |
| 6 | 2013 | 160 | |
| 7 | 1996 | 153 | |
| 8 | 2014 | 104 | |
| 9 | 2014 | 101 | |
| 10 | 2006 | 90 | |
| 11 | 2018 | 82 | |
| 12 | 2003 | 81 | |
| 13 | 2009 | 74 | |
| 14 | 2010 | 69 | |
| 15 | Technique of inserting multiple biliary drains and management. | 1996 | 59 |
| 16 | 1998 | 57 | |
| 17 | 2018 | 57 | |
| 18 | Segmental liver resections for hilar cholangiocarcinoma. | 1998 | 55 |
| 19 | 2014 | 48 | |
| 20 | Stimulated rat liver mitochondrial biogenesis after partial hepatectomy. | 1989 | 47 |
About Masashi Kanai
Masashi Kanai is a scholar working on Oncology, Surgery, Pulmonary and Respiratory Medicine, Molecular Biology and Cancer Research, having authored 163 papers that have together received 4.0k indexed citations. Recurring topics across this work include Cholangiocarcinoma and Gallbladder Cancer Studies (37 papers), Pancreatic and Hepatic Oncology Research (26 papers), Cancer Genomics and Diagnostics (20 papers), Gallbladder and Bile Duct Disorders (15 papers), Lung Cancer Treatments and Mutations (11 papers), Colorectal Cancer Treatments and Studies (10 papers), Curcumin's Biomedical Applications (10 papers) and Hepatocellular Carcinoma Treatment and Prognosis (8 papers). The work is most often cited by research in Molecular Medicine (582 citations), Oncology (1.1k citations), Hepatology (243 citations), Cancer Research (373 citations) and Surgery (871 citations). Masashi Kanai has collaborated with scholars based in Japan, United States and China. Frequent co-authors include Shigemi Matsumoto, Tsutomu Chiba, Daoyan Wei, Keping Xie, Y Nimura, Junichi Kamiya, Suyun Huang, Atsushi Imaizumi, Takafumi Nishimura and Yukiko Mori. Their work appears in journals such as Annals of Oncology, Journal of Clinical Oncology, Cancer Chemotherapy and Pharmacology, International Journal of Clinical Oncology and Pancreas.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.